• Company
    • Overview
    • News & Publications
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Overview
    • Platforms
    • Probes
  • Discovery
    • Overview
    • Kinase Target Area
    • Protease Target Area
    • Development Profiling
  • Clinical Development
    • Pipeline Overview
  • Partnering
    • Approach
    • Contact
  • Careers
    • Who we are
    • Open Positions
  • Contact
    • Contact & Directions

ActivX News Releases

03/21/07 ActivX Biosciences Launches Breakthrough Kinase Platform, KiNativ™
03/15/06 ActivX/Kyorin Begins First U.S. Phase I Study for Novel Anti-Diabetic Drug
03/14/06 ActivX Biosciences Announces Expansion of Strategic Collaboration Agreement with Pfizer Inc. with Multiple Discovery and Developmental Stage Projects
02/10/05 Wall Street Reporter Interview with Dr. John Kozarich
02/09/05 ActivX Biosciences Announces Expansion of Strategic Collaboration Agreement with Pfizer Inc. with Multiple Discovery and Developmental Stage Projects
02/03/05 BioWorld Today article on Kyorin purchase of ActivX Biosciences
02/02/05 ActivX Biosciences Announces Closing of Aquisition by Kyorin Pharmaceutical Co., Ltd.
  Pre 2005 Press

 

ActivX Publications

01/2007 Polo-like kinases inhibited by wortmannin. Labeling site and downstream effects
01/2007 Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor
01/2007 Functional Interrogation of the Kinome using Nucleotide Acyl Phosphates
10/2005 Boro-norleucine as a P1 residue for the design of selective and potent DPP7 inhibitorsent DPP7 inhibitors
10/2005 Synthesis and structure-activity relationship of N-alkyl Gly-boro-Pro inhibitors of DPP4, FAP, and DPP7
04/2005 Clinical Proteomics
02/2005 High-resolution functional proteomics by active-site peptide profiling
01/2005 Wortmannin, a Widely Used Phosphoinositide 3-Kinase Inhibitor, also Potently Inhibits Mammalian Polo-like Kinase
03/2004 Synergistic Computational and Experimental Proteomics Approaches for More Accurate Detection of Active Serine Hydrolases in Yeast
01/2004 Mapping Enzyme Active Sites in Complex Proteomes
08/2003 Prolyl peptidases: a serine protease subfamily with high potential for drug discovery
04/2003 Proteomic Tools for Quantitation by Mass Spectrometry
04/2003 Functional profiling of the proteome with affinity labels
02/2003 Activity-based proteomics: enzyme chemistry redux
02/2003 Inhibitor Focusing: Direct Selection of Drug Targets from Proteomes Using Activity-Based Probes
08/2002 Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness
07/2002 Activity-based probes for functional proteomics
09/2001 Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes
03/2001 Profiling Serine Hydrolase Activities in Complex Proteomes
12/1999 Activity-based protein profiling: The serine hydrolases

    

© 2007 ActivX Biosciences, Inc.
A wholly owned subsidiary of Kyorin Pharmaceutical Co, Ltd.
envelopeinfo@activx.com